226 related articles for article (PubMed ID: 36232600)
1. Genomic Mutations of the STAT5 Transcription Factor Are Associated with Human Cancer and Immune Diseases.
Kim U; Shin HY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232600
[TBL] [Abstract][Full Text] [Related]
2. STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia.
Shahjahani M; Abroun A; Saki N; Bagher Mohammadi SM; Rezaeeyan H
Lab Med; 2020 Jul; 51(4):345-351. PubMed ID: 31860086
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia.
Waight JD; Banik D; Griffiths EA; Nemeth MJ; Abrams SI
J Biol Chem; 2014 May; 289(22):15642-52. PubMed ID: 24753251
[TBL] [Abstract][Full Text] [Related]
4. STAT5 in Cancer and Immunity.
Rani A; Murphy JJ
J Interferon Cytokine Res; 2016 Apr; 36(4):226-37. PubMed ID: 26716518
[TBL] [Abstract][Full Text] [Related]
5. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.
Hennighausen L; Robinson GW
Genes Dev; 2008 Mar; 22(6):711-21. PubMed ID: 18347089
[TBL] [Abstract][Full Text] [Related]
6. STAT5-Driven Enhancers Tightly Control Temporal Expression of Mammary-Specific Genes.
Shin HY; Hennighausen L; Yoo KH
J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):61-71. PubMed ID: 30328555
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer.
LeBaron MJ; Xie J; Rui H
Mol Cancer; 2005 Feb; 4(1):6. PubMed ID: 15686596
[TBL] [Abstract][Full Text] [Related]
8. IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter.
Lowe RM; Genin A; Orgun N; Cron RQ
Genes Immun; 2014; 15(3):137-44. PubMed ID: 24500400
[TBL] [Abstract][Full Text] [Related]
9. [Roles of STAT5 in hematopoietic regulation and blood diseases].
Zhao YZ; Yuan WP; Cheng T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1496-500. PubMed ID: 23257461
[TBL] [Abstract][Full Text] [Related]
10. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
11. Dynamic trafficking of STAT5 depends on an unconventional nuclear localization signal.
Shin HY; Reich NC
J Cell Sci; 2013 Aug; 126(Pt 15):3333-43. PubMed ID: 23704351
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells.
Wittig I; Groner B
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):449-63. PubMed ID: 16375697
[TBL] [Abstract][Full Text] [Related]
13. Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.
Girardot M; Pecquet C; Chachoua I; Van Hees J; Guibert S; Ferrant A; Knoops L; Baxter EJ; Beer PA; Giraudier S; Moriggl R; Vainchenker W; Green AR; Constantinescu SN
Oncogene; 2015 Mar; 34(10):1323-32. PubMed ID: 24681953
[TBL] [Abstract][Full Text] [Related]
14. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.
Wingelhofer B; Neubauer HA; Valent P; Han X; Constantinescu SN; Gunning PT; Müller M; Moriggl R
Leukemia; 2018 Aug; 32(8):1713-1726. PubMed ID: 29728695
[TBL] [Abstract][Full Text] [Related]
15. STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.
Nagy ZS; LeBaron MJ; Ross JA; Mitra A; Rui H; Kirken RA
Mol Cancer; 2009 Aug; 8():67. PubMed ID: 19709433
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells.
Nam S; Williams A; Vultur A; List A; Bhalla K; Smith D; Lee FY; Jove R
Mol Cancer Ther; 2007 Apr; 6(4):1400-5. PubMed ID: 17431118
[TBL] [Abstract][Full Text] [Related]
17. Activation mechanisms of STAT5 by oncogenic Flt3-ITD.
Choudhary C; Brandts C; Schwable J; Tickenbrock L; Sargin B; Ueker A; Böhmer FD; Berdel WE; Müller-Tidow C; Serve H
Blood; 2007 Jul; 110(1):370-4. PubMed ID: 17356133
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology.
Recio C; Guerra B; Guerra-Rodríguez M; Aranda-Tavío H; Martín-Rodríguez P; de Mirecki-Garrido M; Brito-Casillas Y; García-Castellano JM; Estévez-Braun A; Fernández-Pérez L
Oncogene; 2019 Jun; 38(24):4657-4668. PubMed ID: 30783189
[TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription 5 (STAT5).
Buitenhuis M; Coffer PJ; Koenderman L
Int J Biochem Cell Biol; 2004 Nov; 36(11):2120-4. PubMed ID: 15313458
[TBL] [Abstract][Full Text] [Related]
20. Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence.
Li H; Zhang Y; Glass A; Zellweger T; Gehan E; Bubendorf L; Gelmann EP; Nevalainen MT
Clin Cancer Res; 2005 Aug; 11(16):5863-8. PubMed ID: 16115927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
